Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The NR4A2/VGF pathway fuels inflammation-induced neurodegeneration via promoting neuronal glycolysis
Marcel S. Woo, … , Doron Merkler, Manuel A. Friese
Marcel S. Woo, … , Doron Merkler, Manuel A. Friese
Published August 15, 2024
Citation Information: J Clin Invest. 2024;134(16):e177692. https://doi.org/10.1172/JCI177692.
View: Text | PDF
Research Article Inflammation Neuroscience

The NR4A2/VGF pathway fuels inflammation-induced neurodegeneration via promoting neuronal glycolysis

  • Text
  • PDF
Abstract

A disturbed balance between excitation and inhibition (E/I balance) is increasingly recognized as a key driver of neurodegeneration in multiple sclerosis (MS), a chronic inflammatory disease of the central nervous system. To understand how chronic hyperexcitability contributes to neuronal loss in MS, we transcriptionally profiled neurons from mice lacking inhibitory metabotropic glutamate signaling with shifted E/I balance and increased vulnerability to inflammation-induced neurodegeneration. This revealed a prominent induction of the nuclear receptor NR4A2 in neurons. Mechanistically, NR4A2 increased susceptibility to excitotoxicity by stimulating continuous VGF secretion leading to glycolysis-dependent neuronal cell death. Extending these findings to people with MS (pwMS), we observed increased VGF levels in serum and brain biopsies. Notably, neuron-specific deletion of Vgf in a mouse model of MS ameliorated neurodegeneration. These findings underscore the detrimental effect of a persistent metabolic shift driven by excitatory activity as a fundamental mechanism in inflammation-induced neurodegeneration.

Authors

Marcel S. Woo, Lukas C. Bal, Ingo Winschel, Elias Manca, Mark Walkenhorst, Bachar Sevgili, Jana K. Sonner, Giovanni Di Liberto, Christina Mayer, Lars Binkle-Ladisch, Nicola Rothammer, Lisa Unger, Lukas Raich, Alexandros Hadjilaou, Barbara Noli, Antonio L. Manai, Vanessa Vieira, Nina Meurs, Ingrid Wagner, Ole Pless, Cristina Cocco, Samuel B. Stephens, Markus Glatzel, Doron Merkler, Manuel A. Friese

×

Figure 2

NR4A2-induced VGF mediates neuronal susceptibility to excitotoxicity.

Options: View larger image (or click on image) Download as PowerPoint
NR4A2-induced VGF mediates neuronal susceptibility to excitotoxicity.
(A...
(A) Nr4a2 mRNA expression in NeuN+ nuclei sorted from spinal cords of healthy mice (n = 3) and acute EAE mice (n = 5) in relative units (RU). (B) Eigengene correlation matrix and dendrogram of weighted gene correlated network analysis (WGCNA) with 502 neuron-specific transcriptome data sets. (C) Enrichment analysis of the inflamed neuronal signature (ranked gene list retrieved from ref. 9) in module “darkgreen”. (D) GO term biological process enrichment analysis of the module “darkgreen”. Size shows number of genes of GO terms, color shows significance. (E) Heatmap of top 10 genes from the module “darkgreen,” which are differently expressed in neurons during EAE. (F) Chromatin immunoprecipitation (ChIP) was performed using an antibody against NR4A2 and an IgG control from 3 pooled mouse cortices. PCR primers were designed to amplify approximately 100 nucleotides flanking the canonical nuclear receptor binding (NRB) motif in the mouse Vgf promoter (left) or the 3′ untranslated region of Vgf as control (right). (G) VGF MFI in neuronal cultures after vehicle or glutamate stimulation (n = 4 per group). Scale bar: 50 μm. (H and I) Relative VGF MFI in neurons that overexpress mScarlet (controls), Nr4a2 or were exposed to 50 nM Ip7e (H; n = 4), and neurons that overexpress Nr4a1 or Nr4a3 (I; n = 6). Data is normalized to mScarlet-overexpressing control neurons. Scale bar: 20 μm. (J) VGF+ neurons in cortices of WT and Grm8–/– mice (n = 5). Scale bar: 300 μm. (K) Cell viability (RU) of WT and Vgf–/– neurons that overexpress Nr4a2 and were exposed to glutamate (n = 5). Points represent individual experiments, additionally mean is shown. If not stated otherwise, unpaired t test with FDR correction for multiple comparisons was used. *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts